On the other hand, Gal-3-positive tumor cells receive the CCL2-CCR2 signal, which leads to a decrease in the catalytic activity of NOX, culminating in decreases in the ROS and OXPHS levels. This evidence concerns the gene LGALS3 and neoplasm.